NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that its third quarter revenues rose 8 percent year over year, thanks largely to a 13 percent increase in reported revenues from its diagnostics business.

For the three months ended Oct. 1, the firm reported total revenues of $554.3 million, up from $514.5 million a year earlier, beating Wall Street analyst expectations for revenues of $552.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.